Stoke Therapeutics, Inc. ($STOK)
Filing Information
| Accession Number | 0001966716-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 19, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
8,895
Total Value
$285,900.96
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GENERAL COUNSEL & CORP SEC | Common Stock | โ | Mar 17, 2026 | Sale | 2,476 | $32.74 | $81,062.75 | 35,255 | Direct | โ | View Details | |
GENERAL COUNSEL & CORP SEC | Common Stock | โ | Mar 17, 2026 | Sale | 1,791 | $33.38 | $59,775.34 | 33,464 | Direct | โ | View Details | |
GENERAL COUNSEL & CORP SEC | Common Stock | โ | Mar 18, 2026 | Sale | 4,222 | $31.28 | $132,080.20 | 29,242 | Direct | โ | View Details | |
GENERAL COUNSEL & CORP SEC | Common Stock | โ | Mar 18, 2026 | Sale | 334 | $31.79 | $10,617.46 | 28,908 | Direct | โ | View Details | |
GENERAL COUNSEL & CORP SEC | Common Stock | โ | Mar 18, 2026 | Sale | 72 | $32.85 | $2,365.20 | 28,836 | Direct | โ | View Details |